Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPz Cussons Regulatory News (PZC)

Share Price Information for Pz Cussons (PZC)

Share Price is delayed by 15 minutes
Get Live Data
87.40    2.10 (2.46%)
Bid:
87.00
Ask:
88.90
Spread: 1.90 (2.184%)
Market Cap: £367.39m
PZC Live PriceLast checked at - London Stock Exchange

Intraday Pz Cussons Share Chart

AGM Trading Statement

28 Sep 2016 07:00

RNS Number : 9935K
PZ CUSSONS PLC
28 September 2016
Β 

28 September 2016

PZ Cussons Plc

(the "Group")

Β 

AGM Trading Statement

Β 

PZ Cussons Plc, a leading international consumer products group, today issues the following trading update which covers the period 1 June 2016 to 27 September 2016, in advance of its Annual General Meeting, to be held at 10:30 today.

Β 

Overview of financial performance and position

Β 

The board is pleased to announce that the overall performance of the Group during the period has been in line with expectations. The financial position of the Group remains strong with cash generation during the period also in line with expectations.

Β 

Trading Update

Β 

Europe

Β 

In the UK, performance in the washing and bathing division has been robust across the brand portfolio of Imperial Leather, Original Source and Carex with the Group's renovation and innovation strategy continuing to play an important role in holding or growing market shares in a competitive trading environment.

Β 

In the beauty division, a poor summer has adversely affected sales of St Tropez in the UK, however sales in the US have been particularly strong. A significant number of new product launches will take place across the portfolio of St Tropez, Sanctuary, Fudge and Charles Worthington over the remainder of the financial year.

Β 

Performance in the smaller markets of Poland and Greece has been in line with expectations.

Β 

Asia

Β 

In Australia, whilst tough trading conditions are evident in all channels, there is a strong new product pipeline in place for the remainder of the year across all categories of personal care, beauty, home care and food and nutrition.

Β 

In Indonesia, revenue growth has continued to be strong across both babycare and non-babycare portfolios and performance in the smaller markets of Thailand and the Middle East has been in line with expectations.

Β 

Asian results are also benefiting on translation to sterling as a result of the weaker pound.

Β 

Africa

Β 

In Nigeria, following the introduction of the new flexible exchange rate regime in June which led to a 40% devaluation of the naira, there has been some improvement in liquidity although the currency has continued to weaken on both the interbank and secondary markets.

Β 

Performance across personal care, home care, electricals and food and nutrition has been robust in the period. The Group's diverse brand portfolio with product offerings at all price points is working well in an environment where the consumer is under significant inflationary pressure.

Β 

Performance in the smaller markets of Ghana and Kenya has been in line with expectations.

Β 

Outlook

Β 

The strength of the Group's brand portfolio and new product pipeline is serving us well and, together with a continued focus on costs, leaves the Group well placed to manage the challenging trading conditions that exist in most markets.

Β 

The Group's balance sheet remains strong and well placed to pursue new opportunities as they arise.

Β 

A further trading update will be made on 15 December 2016.

Β 

Β 

Enquiries:

Β 

PZ Cussons Plc

Brandon Leigh

Β 

Tel: 0161 435 1236

Instinctif

Tim Linacre / Guy Scarborough

Tel: 020 7457 2020

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
AGMEDLFLQKFXBBZ
Date   Source Headline
1st Apr 201011:21 amRNSDirector/PDMR Shareholding
25th Mar 20104:51 pmRNSDirector/PDMR Shareholding
19th Feb 201010:42 amRNSDirector/PDMR Shareholding
3rd Feb 20106:00 pmRNSDirector/PDMR Shareholding
26th Jan 20107:00 amRNSHalf Yearly Report
9th Dec 20097:00 amRNSTrading Update
26th Nov 20097:00 amRNSAppointment of Richard Harvey as Chairman-elect
20th Oct 20095:15 pmRNSHolding(s) in Company
19th Oct 20094:27 pmRNSDirector/PDMR Shareholding
6th Oct 20095:57 pmRNSResult of AGM
5th Oct 20097:00 amRNSInterim Management Statement
18th Sep 20097:00 amRNSAnnual Information Update
3rd Sep 20093:15 pmRNSDirector/PDMR Shareholding
25th Aug 20098:00 amRNSAnnual Financial Report
17th Aug 20097:00 amRNSDirector/PDMR Shareholding
31st Jul 20091:17 pmRNSDirector/PDMR Shareholding
30th Jul 20096:00 pmRNSDirector/PDMR Shareholding
28th Jul 20097:00 amRNSFinal Results
9th Jul 20094:35 pmRNSPrice Monitoring Extension
10th Jun 20097:00 amRNSTrading Update
2nd Jun 20099:11 amRNSNotice of Trading Update and Preliminary Results
8th Apr 20097:00 amRNSInterim Management Statement
13th Feb 20094:32 pmRNSDirector/PDMR Shareholding
27th Jan 20097:00 amRNSHalf Yearly Report
9th Dec 20087:00 amRNSTrading Statement
27th Nov 20084:36 pmRNSPrice Monitoring Extension
12th Nov 20082:19 pmRNSDirector/PDMR Shareholding
3rd Nov 200812:07 pmRNSDirector/PDMR Shareholding
6th Oct 20087:00 amRNSNotice of Trading Update
2nd Oct 20084:47 pmRNSDirector/PDMR Shareholding
29th Sep 20087:00 amRNSInterim Management Statement
18th Sep 20087:00 amRNSAppointment of Joint Broker
17th Sep 20087:00 amRNSAnnual Information Update
29th Jul 20087:00 amRNSFinal Results
5th Jun 20087:00 amRNSTrading Update
14th Apr 200812:30 pmRNSDirector/PDMR Shareholding
8th Apr 20087:00 amRNSInterim Management Statement
11th Mar 20089:05 amRNSPurchased Shares
29th Jan 20087:01 amRNSAcquisition
29th Jan 20087:01 amRNSInterim Results
3rd Jan 200810:35 amRNSDirector Declaration
6th Dec 20077:00 amRNSTrading Statement
19th Nov 20072:04 pmRNSDirectorate Change
16th Oct 20079:33 amRNSDirector/PDMR Shareholding
12th Oct 200710:58 amRNSDirector/PDMR Shareholding
10th Oct 20072:59 pmRNSDirector/PDMR Shareholding
24th Sep 20077:01 amRNSInterim Management Statement
20th Sep 20077:01 amRNSAnnual Information Update
8th Aug 20074:05 pmRNSDirector/PDMR Shareholding
2nd Aug 20076:07 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.